Literature DB >> 8953533

Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease.

P J Burton1, C Thornsberry, Y Cheung Yee, J L Watts, R J Yancey.   

Abstract

Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of < or = 2 micrograms/ml and > or = 21 mm for susceptible, 4 micrograms/ml and 18-20 mm for intermediate, and > or = 8 micrograms/ml and > or = 17 mm for resistant classification for swine pathogens. When these breakpoints were applied to data from a previous study using bovine pathogens, only 1 minor interpretive error occurred.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953533     DOI: 10.1177/104063879600800411

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Antimicrobial susceptibility of Bordetella bronchiseptica isolates from porcine respiratory tract infections.

Authors:  Kristina Kadlec; Corinna Kehrenberg; Jürgen Wallmann; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Ceftiofur regulates LPS-induced production of cytokines and improves LPS-induced survival rate in mice.

Authors:  Xinxin Ci; Hongyu Li; Yu Song; Na An; Qinlei Yu; Fanqin Zeng; Xuming Deng
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

3.  Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002.

Authors:  Daniel A Tadesse; Shaohua Zhao; Emily Tong; Sherry Ayers; Aparna Singh; Mary J Bartholomew; Patrick F McDermott
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

4.  The influence of enrofloxacin, florfenicol, ceftiofur and E. coli LPS interaction on T and B cells subset in chicks.

Authors:  Chrząstek Klaudia; Wieliczko Alina
Journal:  Vet Res Commun       Date:  2015-02-10       Impact factor: 2.459

5.  Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes.

Authors:  Sandra Prüller; Ulrike Rensch; Diana Meemken; Heike Kaspar; Peter A Kopp; Günter Klein; Corinna Kehrenberg
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

6.  Considerations for studying transmission of antimicrobial resistant enteric bacteria between wild birds and the environment on intensive dairy and beef cattle operations.

Authors:  Kristin Tormoehlen; Yvette J Johnson-Walker; Emily W Lankau; Maung San Myint; John A Herrmann
Journal:  PeerJ       Date:  2019-02-27       Impact factor: 2.984

7.  Recommendation for a Standardised Method of Broth Microdilution Susceptibility Testing for Porcine Bordetella bronchiseptica.

Authors:  Sandra Prüller; Cornelia Frömke; Heike Kaspar; Günter Klein; Lothar Kreienbrock; Corinna Kehrenberg
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.